Steven L. Bramer

1.4k total citations
49 papers, 1.1k citations indexed

About

Steven L. Bramer is a scholar working on Pharmacology, Analytical Chemistry and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Steven L. Bramer has authored 49 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pharmacology, 18 papers in Analytical Chemistry and 10 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Steven L. Bramer's work include Analytical Methods in Pharmaceuticals (18 papers), Antibiotics Pharmacokinetics and Efficacy (15 papers) and Pharmacogenetics and Drug Metabolism (9 papers). Steven L. Bramer is often cited by papers focused on Analytical Methods in Pharmaceuticals (18 papers), Antibiotics Pharmacokinetics and Efficacy (15 papers) and Pharmacogenetics and Drug Metabolism (9 papers). Steven L. Bramer collaborates with scholars based in United States, United Kingdom and Spain. Steven L. Bramer's co-authors include Suresh Mallikaarjun, William P. Forbes, Daniel E. Salazar, Beatrice Kallungal, Allan N. Maroli, Constantin Efthymiopoulos, Ajit Suri, Susan E. Shoaf, Prasad N.V Tata and Christopher A. Zimmer and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Pharmaceutical Research and Clinical Pharmacology & Therapeutics.

In The Last Decade

Steven L. Bramer

49 papers receiving 1.1k citations

Peers

Steven L. Bramer

PHARM

CCM

PMH

G. Bianchetti France

L Paalzow Sweden

Samuel Vožeh Switzerland

France Varin Canada

N. A. Klitgaard Denmark

J. Kuhlmann Germany

M. Kristensen Denmark

Hartmut Derendorf United States

E. J. Triggs Australia

Donald J. Weidler United States

G. Bianchetti France

Steven L. Bramer

277 ×1.1

PHARM

248 ×1.2

CCM

255 ×1.3

PMH

163 ×0.9

265 ×1.5

Citations per year, relative to Steven L. Bramer Steven L. Bramer (= 1×) peers G. Bianchetti

Countries citing papers authored by Steven L. Bramer

Since Specialization

Citations

This map shows the geographic impact of Steven L. Bramer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven L. Bramer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven L. Bramer more than expected).

Fields of papers citing papers by Steven L. Bramer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven L. Bramer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven L. Bramer. The network helps show where Steven L. Bramer may publish in the future.

Co-authorship network of co-authors of Steven L. Bramer

This figure shows the co-authorship network connecting the top 25 collaborators of Steven L. Bramer. A scholar is included among the top collaborators of Steven L. Bramer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven L. Bramer. Steven L. Bramer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shoaf, Susan E., Steven L. Bramer, Patricia Bricmont, & Christopher A. Zimmer. (2007). Pharmacokinetic and Pharmacodynamic Interaction Between Tolvaptan, a Non-Peptide AVP Antagonist, and Furosemide or Hydrochlorothiazide. Journal of Cardiovascular Pharmacology. 50(2). 213–222. 46 indexed citations

Findling, Robert L., J Blumer, Ralph E. Kauffman, et al.. (2004). Pharmacokinetic effects of aripiprazole in children and adolescents with conduct disorder. The International Journal of Neuropsychopharmacology. 7. 10 indexed citations

Mallikaarjun, Suresh, Daniel E. Salazar, & Steven L. Bramer. (2004). Pharmacokinetics, Tolerability, and Safety of Aripiprazole following Multiple Oral Dosing in Normal Healthy Volunteers. The Journal of Clinical Pharmacology. 44(2). 179–187. 145 indexed citations

Bramer, Steven L., et al.. (2003). Extended application of an LC–MS/MS method for the analysis of vesnarinone and its metabolites in human urine and dialysate fluid. Journal of Pharmaceutical and Biomedical Analysis. 33(4). 711–717. 2 indexed citations

Bramer, Steven L. & Beatrice Kallungal. (2003). Clinical considerations in study designs that use cotinine as a biomarker. Biomarkers. 8(3-4). 187–203. 96 indexed citations

Miyamoto, Gohachiro, et al.. (2002). The Pharmacokinetics of Toborinone in Subjects with Congestive Heart Failure and Concomitant Renal Impairment and/or Concomitant Hepatic Impairment. The Journal of Clinical Pharmacology. 42(12). 1318–1325. 3 indexed citations

Tata, Prasad N.V, et al.. (2001). Determination of cilostazol and its metabolites in human urine by high performance liquid chromatography. Journal of Pharmaceutical and Biomedical Analysis. 24(3). 381–389. 18 indexed citations

Suri, Ajit, William P. Forbes, & Steven L. Bramer. (1999). Effects of CYP3A Inhibition on the Metabolism of Cilostazol. Clinical Pharmacokinetics. 37(Supplement 2). 61–68. 33 indexed citations

Bramer, Steven L., et al.. (1999). The Preparation of Soft Gelatin Capsules for a Radioactive Tracer Study. Pharmaceutical Development and Technology. 4(4). 507–513. 7 indexed citations

10.

Tata, Prasad N.V, et al.. (1999). Simultaneous quantitative determination of cilostazol and its metabolites in human plasma by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 728(2). 251–262. 30 indexed citations

11.

Bramer, Steven L. & William P. Forbes. (1999). Effect of Hepatic Impairment on the Pharmacokinetics of a Single Dose of Cilostazol. Clinical Pharmacokinetics. 37(Supplement 2). 25–32. 18 indexed citations

12.

Bramer, Steven L., William P. Forbes, & Suresh Mallikaarjun. (1999). Cilostazol Pharmacokinetics after Single and Multiple Oral Doses in Healthy Males and Patients with Intermittent Claudication Resulting from Peripheral Arterial Disease. Clinical Pharmacokinetics. 37(Supplement 2). 1–11. 63 indexed citations

13.

Bramer, Steven L. & William P. Forbes. (1999). Relative Bioavailability and Effects of a High Fat Meal on Single Dose Cilostazol Pharmacokinetics. Clinical Pharmacokinetics. 37(Supplement 2). 13–23. 49 indexed citations

14.

Bramer, Steven L., et al.. (1999). Effect of Multiple Cilostazol Doses on Single Dose Lovastatin Pharmacokinetics in Healthy Volunteers. Clinical Pharmacokinetics. 37(Supplement 2). 69–77. 15 indexed citations

15.

Suri, Ajit, William P. Forbes, & Steven L. Bramer. (1998). Pharmacokinetics of Multiple‐Dose Oral Cilostazol in Middle‐Age and Elderly Men and Women. The Journal of Clinical Pharmacology. 38(2). 144–150. 23 indexed citations

16.

Efthymiopoulos, Constantin, Steven L. Bramer, Allan N. Maroli, et al.. (1997). Grepafloxacin Pharmacokinetics in Individuals with Hepatic Dysfunction. Clinical Pharmacokinetics. 33(Supplement 1). 25–31. 11 indexed citations

17.

Efthymiopoulos, Constantin, Steven L. Bramer, & Allan N. Maroli. (1997). Effect of Age and Gender on the Pharmacokinetics of Grepafloxacin. Clinical Pharmacokinetics. 33(Supplement 1). 9–17. 17 indexed citations

18.

Efthymiopoulos, Constantin, et al.. (1997). Effect of Renal Impairment on the Pharmacokinetics of Grepafloxacin. Clinical Pharmacokinetics. 33(Supplement 1). 32–38. 18 indexed citations

19.

Efthymiopoulos, Constantin, Steven L. Bramer, & Allan N. Maroli. (1997). Pharmacokinetics of Grepafloxacin after Oral Administration of Single and Repeat Doses in Healthy Young Males. Clinical Pharmacokinetics. 33(Supplement 1). 1–8. 54 indexed citations

20.

Bramer, Steven L., et al.. (1989). Biologic Activity of 5′-Deoxy-5-fluorouridine by Rectal Administration. Pharmaceutical Research. 6(4). 318–322. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact